$58.10
-0.72-1.22%
At close: -
$58.23
0.130.22%
After Hours: 4:03 PM EDT
Comments
Loading...
BioMarin Pharmaceutical Earnings Estimates, EPS & Revenue | NASDAQ:BMRN | Benzinga
BioMarin Pharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 4
EPS Estimate
$0.851
Quarterly Revenue Estimate
$760.39M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$2.95B
Analyze the earnings history of BioMarin Pharmaceutical using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BMRN | Biomarin Pharmaceutical | $0.96 | $0.85 | — | — | $712.03M | $760.39M | — | — | 08/04/2025 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.71 | $0.71 | $1.13 | 59.15% | $648.83M | $740.72M | $745.14M | 0.60% | 05/01/2025 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.49 | $0.53 | $0.92 | 24.32% | $646.21M | $713.44M | $747.00M | 5.06% | 02/19/2025 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.46 | $0.52 | $0.91 | 75.00% | $581.33M | $700.14M | $745.74M | 6.51% | 10/29/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.54 | $0.35 | $0.96 | 174.29% | $595.27M | $662.05M | $712.03M | 7.68% | 08/05/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.60 | $0.34 | $0.71 | 108.82% | $596.41M | $651.79M | $648.83M | -0.45% | 04/24/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.00 | $0.23 | $0.49 | 113.04% | $537.54M | $636.67M | $646.21M | 1.50% | 02/22/2024 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.04 | $0.22 | $0.46 | 109.09% | $505.34M | $608.33M | $581.33M | -4.44% | 11/01/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.15 | $0.47 | $0.54 | 14.89% | $533.80M | $591.46M | $595.27M | 0.65% | 07/31/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.63 | $0.18 | $0.60 | 233.33% | $519.36M | $570.62M | $596.41M | 4.52% | 04/26/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.32 | -$0.07 | $0.00 | 100.00% | $449.81M | $536.97M | $537.54M | 0.11% | 02/27/2023 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.20 | -$0.01 | -$0.04 | -300.00% | $408.74M | $518.91M | $505.34M | -2.61% | 10/26/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.07 | $0.11 | $0.59 | 436.36% | $501.69M | $521.47M | $533.80M | 2.36% | 08/03/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.09 | — | $0.17 | — | $486.03M | $507.52M | $519.36M | 2.33% | 04/27/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.12 | -$0.32 | -$0.32 | 0.00% | $452.12M | $442.39M | $449.81M | 1.68% | 02/23/2022 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $4.01 | -$0.25 | -$0.20 | 20.00% | $476.78M | $435.32M | $408.74M | -6.11% | 10/27/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.16 | -$0.11 | $0.07 | 163.64% | $429.49M | $448.79M | $501.69M | 11.79% | 07/28/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.44 | -$0.10 | $0.09 | 190.00% | $502.07M | $446.45M | $486.03M | 8.87% | 04/29/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.08 | -$0.19 | $0.12 | 163.16% | $454.44M | $440.23M | $452.12M | 2.70% | 02/25/2021 | Get Alert |
| BMRN | Biomarin Pharmaceutical | $0.30 | $1.29 | $4.01 | 210.85% | $461.10M | $454.64M | $476.78M | 4.87% | 11/05/2020 | Get Alert |
| BMRN | Biomarin Pharmaceutical | -$0.29 | -$0.11 | -$0.16 | -45.45% | $387.76M | $418.61M | $429.49M | 2.60% | 08/04/2020 | Get Alert |
BioMarin Pharmaceutical (BMRN) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-01 | $1.13 | $0.71 | 59.2 % |
| Q4 | 2025-02-19 | $0.92 | $0.53 | 24.3 % |
| Q3 | 2024-10-29 | $0.91 | $0.52 | 75.0 % |
| Q2 | 2024-08-05 | $0.96 | $0.35 | 174.3 % |
BioMarin Pharmaceutical (BMRN) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-01 | $745.15M | $740.72M | 0.60 % |
| Q4 | 2025-02-19 | $747.00M | $713.44M | 5.06 % |
| Q3 | 2024-10-29 | $745.74M | $700.14M | 6.51 % |
| Q2 | 2024-08-05 | $712.03M | $662.05M | 7.68 % |
FAQ
When is BioMarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?
BioMarin Pharmaceutical (BMRN) is scheduled to report earnings on August 4, 2025. The last reported earnings were for reported on May 1, 2025 for Q1.
What were the latest earnings per share (EPS) for BioMarin Pharmaceutical (NASDAQ:BMRN)?
The Actual EPS was $1.13, which beat the estimate of $0.71.
What were BioMarin Pharmaceutical’s (NASDAQ:BMRN) revenues?
The Actual Revenue was $745.1M, which beat the estimate of $740.7M.
Browse earnings estimates, EPS, and revenue on all stocks.
